<DOC>
	<DOCNO>NCT01552707</DOCNO>
	<brief_summary>The present prospective , randomize study , compare spinal fusion obtain instrumentation use biologic product ( patient 's mesenchymal cell obtain his/her bone marrow fix human bone tissue form donor ) , current procedure consist instrumented spinal fusion use patient 's bone obtain his/her iliac crest . The work hypothesis proposes tissue engineering valid useful technique achieve bone regeneration , avoid need obtain patient 's iliac crest associate morbidity .</brief_summary>
	<brief_title>Safety Study Mesenchymal Stem Cells Spinal Fusion</brief_title>
	<detailed_description>Prospective , open-label , randomize , parallel , single-dose phase I-II clinical trial 62 patient affect L4-L5 degenerative spondylolisthesis grade I-II accord Meyerding and/or L4-L5 degenerative discopathy need spinal fusion enter trial primary objective assess feasibility safety `` ex-vivo '' expand autologous mesenchymal stem cell fix allogenic bone tissue spinal fusion . Secondary objective assess efficacy implantation imaging ( computerized helicoidal tomography X-ray ) clinical questionnaire ( pain visual analogue scale , quality life SF-36 Oswestry Disability Index ) . Patients randomize one two treatment arm ( instrumented spinal fusion tissue engineering product compose `` ex-vivo '' expand autologous mesenchymal stem cell fix allogenic bone tissue spinal fusion standard treatment instrument spinal fusion patient 's bone iliac crest ) . Thereafter , patient follow 12 month . Imaging assessment do independent blinded radiologist .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<criteria>L4L5 degenerative spondylolisthesis grade III Meyerding isolate associated one level , and/or L4L5 degenerative discopathy isolate associated one level . 18 85 year age ( male female ) Informed Consent Form sign The patient able understand nature study Previous spine surgery L4 isthmic spondylolisthesis Smoker ( 10 cigarette day ) Systemic local infection Patients treated steroid ( oral systemic ) within 3 month enter study , treat biphosphonates 10 year Positive serology HIV1 HIV2 , Hepatitis B ( HBsAg ) , Hepatitis C ( AntiHCVAb ) Syphilis . Pregnant woman intend become pregnant , breath feeding Neoplasia within previous 5 year , without remission Immunosuppressive state ( except diabetes mellitus . Treatment therapy allow ) Significant abnormal laboratory test contraindicate surgery . Participation another clinical trial treat investigational medicinal product previous 3 month Other pathologic condition circumstance difficult participation study accord medical criterion The patient accept followedup period could exceed clinical trial length The patient legally dependent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Spondylolisthesis</keyword>
	<keyword>Degenerative discopathy</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Bone marrow</keyword>
	<keyword>Tissue engineering</keyword>
	<keyword>Spinal fusion</keyword>
</DOC>